# Effects of Triphala and VSL#3 Probiotic Supplementation on Stool Microbiome Profiles and Inflammation

> **NCT03907501** · NA · TERMINATED · sponsor: **University of California, San Diego** · enrollment: 75 (actual)

## Conditions studied

- Human Microbiome

## Interventions

- **DIETARY_SUPPLEMENT:** Synbiotic
- **DIETARY_SUPPLEMENT:** Probiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03907501
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-01
- **Primary completion:** 2021-05-05
- **Final completion:** 2021-07-12
- **Target enrollment:** 75 (ACTUAL)
- **Why stopped:** COVID-19 related personnel, reagent and budget related impacts
- **Last updated:** 2023-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03907501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03907501, "Effects of Triphala and VSL#3 Probiotic Supplementation on Stool Microbiome Profiles and Inflammation". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03907501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*